ProNutri Dairy Foods — Implementation Plan and Timeline
The implementation timeline spans an 18-month pre-operations phase from financial close to the commencement of commercial production. The critical path runs through environmental approvals, building construction, equipment procurement and installation, and HACCP certification. The Gantt chart below illustrates the sequencing and interdependencies…
Section 15 · Business Plan
Implementation Plan and Timeline
The implementation timeline spans an 18-month pre-operations phase from financial close to the commencement of commercial production. The critical path runs through environmental approvals, building construction, equipment procurement and installation, and HACCP certification. The Gantt chart below illustrates the sequencing and interdependencies…
The implementation timeline spans an 18-month pre-operations phase from financial close to the commencement of commercial production. The critical path runs through environmental approvals, building construction, equipment procurement and installation, and HACCP certification. The Gantt chart below illustrates the sequencing and interdependencies of key implementation milestones.
15.1 Implementation Gantt Chart
15.2 Key Milestones
| Milestone | Target Date | Dependency |
|---|---|---|
| Financial Close | Month 1 | Completion of due diligence and legal agreements |
| Environmental Impact Assessment Approved | Month 6 | DFFE approval of EIA application |
| Building Construction Complete | Month 12 | Site preparation and civil works |
| Major Equipment Delivered and Installed | Month 15 | Import logistics and installation |
| HACCP Certification Obtained | Month 17 | Facility completion and QA documentation |
| Trial Production Complete | Month 17 | Equipment commissioning and product testing |
| Commercial Production Commences | Month 18 | All regulatory approvals and customer contracts |
| Break-Even (Monthly Cash Flow) | Month 32 | 14 months post commercial start |
| Phase 2 Capacity Expansion Initiated | Month 30 | Subject to demand and funding availability |
This document contains proprietary and confidential information. Distribution without written consent is prohibited.